Benefits of Long-Term Pulmonary Rehabilitation Maintenance Program in Patients with Severe Chronic Obstructive Pulmonary Disease. Three-Year Follow-up

GÙell, Maria-Rosa; Cejudo, Pilar; Ortega, Francisco; Puy, M. Carmen; Rodríguez-Trigo, Gema; Pijoan, José Ignacio; Martinez-Indart, Lorea; Gorostiza, Amaia; Bdeir, Khaled; Celli, Bartolome; Galdiz, Juan B.; Güell, Maria-Rosa
March 2017
American Journal of Respiratory & Critical Care Medicine;3/1/2017, Vol. 195 Issue 5, p622
Academic Journal
journal article
Rationale: In chronic obstructive pulmonary disease (COPD), the benefits of pulmonary rehabilitation (PR) tend to wane over time. Whether maintenance techniques may help sustain the benefits achieved after completion of the initial PR program remains controversial.Objectives: To determine whether a long-term (3-yr) maintenance program after PR preserves the short-term effects on outcomes in patients with COPD.Methods: This was a multicenter prospective randomized trial including 143 patients with moderate-severe COPD, with 3 years of PR maintenance following an 8-week outpatient PR program. Patients were randomized to maintenance intervention group (IG) and standard monitoring program or control group (CG). The effects on BODE index, 6-minute-walk test distance (6MWD), and health-related quality of life were compared at 12, 24, and 36 months.Measurements and Main Results: A total of 138 (96.5%) completed the 8-week program. At this time, all outcomes (BODE, 6MWD, and health-related quality of life) showed clinically and statistically significant improvements (P ≤ 0.001). During the follow-up period, the magnitude of change in 6MWD differed between IG and CG (P = 0.042), with a slight initial increase in the IG during the first year and smaller decline afterward. The BODE index changes differed between baseline and measurements at Month 24 (P = 0.043). At 3 years, the adherence rate of IG patients was 66% and 17% for the CG group (P < 0.001).Conclusions: This study shows a 2-year beneficial effect of a program of rehabilitation maintenance on the BODE index and 6MWD when compared with a standard strategy. This effect vanishes after the second year of follow-up. Clinical trial registered with www.clinicaltrials.gov (NCT 01090999).


Related Articles

  • Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study. Valipour, Arschang; Slebos, Dirk-Jan; Herth, Felix; Darwiche, Kaid; Wagner, Manfred; Ficker, Joachim H.; Petermann, Christoph; Hubner, Ralf-Harto; Stanzel, Franz; Eberhardt, Ralf; IMPACT Study Team // American Journal of Respiratory & Critical Care Medicine;11/1/2016, Vol. 194 Issue 9, p1073 

    Rationale: Endobronchial valves (EBVs) have been successfully used in patients with severe heterogeneous emphysema to improve lung physiology. Limited available data suggest that EBVs are also effective in homogeneous emphysema.Objectives: To evaluate the efficacy and...

  • Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction. Martinez, Fernando J.; Vestbo, Jørgen; Anderson, Julie A.; Brook, Robert D.; Celli, Bartolome R.; Cowans, Nicholas J.; Crim, Courtney; Dransfield, Mark; Kilbride, Sally; Yates, Julie; Newby, David E.; Niewoehner, Dennis; Calverley, Peter M. A.; SUMMIT Investigators // American Journal of Respiratory & Critical Care Medicine;4/1/2017, Vol. 195 Issue 7, p881 

    Rationale: Inhaled corticosteroids have been shown to decrease exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Their effects in patients with milder airflow obstruction remain unclear.Objectives: This was an analysis of...

  • Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts. Keene, Jason D.; Jacobson, Sean; Kechris, Katerina; Kinney, Gregory L.; Foreman, Marilyn G.; Doerschuk, Claire M.; Make, Barry J.; Curtis, Jeffrey L.; Rennard, Stephen I.; Barr, R. Graham; Bleecker, Eugene R.; Kanner, Richard E.; Kleerup, Eric C.; Hansel, Nadia N.; Woodruff, Prescott G.; Han, MeiLan K.; Paine III, Robert; Martinez, Fernando J.; Bowler, Russell P.; O'Neal, Wanda K. // American Journal of Respiratory & Critical Care Medicine;2/15/2017, Vol. 195 Issue 4, p473 

    Rationale: Chronic obstructive pulmonary disease exacerbations are associated with disease progression, higher healthcare cost, and increased mortality. Published predictors of future exacerbations include previous exacerbation, airflow obstruction, poor overall health, home oxygen...

  • Effect of Continuous Positive Airway Pressure on Airway Reactivity in Asthma. A Randomized, Sham-controlled Clinical Trial. Holbrook, Janet T.; Sugar, Elizabeth A.; Brown, Robert H.; Drye, Lea T.; Irvin, Charles G.; Schwartz, Alan R.; Tepper, Robert S.; Wise, Robert A.; Yasin, Razan Z.; Busk, Michael F.; American Lung Association Airways Clinical Research Centers // Annals of the American Thoracic Society;Nov2016, Vol. 13 Issue 11, p1940 

    Rationale: Studies have demonstrated that application of stress suppresses airway smooth muscle contractility. In animal models of asthma, continuous positive airway pressure (CPAP) reduced airway reactivity. Short-term studies of CPAP in patients with asthma showed reductions in...

  • The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema. Li, Shiyue; Wang, Guangfa; Wang, Changhui; Gao, Xinglin; Jin, Faguang; Yang, Huaping; Han, Baohui; Zhou, Rui; Chen, Chengshui; Chen, Liangan; Bai, Chunxue; Shen, Huahao; Herth, Felix J.F.; Zhong, Nanshan // Respiration;Jun2019, Vol. 97 Issue 5, p416 

    Background: Chronic obstructive pulmonary disease (COPD) has become a leading cause of morbidity and mortality in China, with tobacco smoke, air pollution, and occupational biohazards being the major risk factors. Objectives: The REACH trial is a multicenter, prospective, randomized controlled...

  • A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease. Martinez, Fernando J.; Mannino, David; Leidy, Nancy Kline; Malley, Karen G.; Bacci, Elizabeth D.; Barr, R. Graham; Bowler, Russ P.; Han, MeiLan K.; Houfek, Julia F.; Make, Barry; Meldrum, Catherine A.; Rennard, Stephen; Thomashow, Byron; Walsh, John; Yawn, Barbara P.; High-Risk-COPD Screening Study Group * // American Journal of Respiratory & Critical Care Medicine;3/15/2017, Vol. 195 Issue 6, p748 

    Rationale: Chronic obstructive pulmonary disease (COPD) is often unrecognized and untreated.Objectives: To develop a method for identifying undiagnosed COPD requiring treatment with currently available therapies (FEV1 <60% predicted and/or exacerbation...

  • A Multicenter Randomized Trial Assessing the Efficacy of Helium/Oxygen in Severe Exacerbations of Chronic Obstructive Pulmonary Disease. Jolliet, Philippe; Ouanes-Besbes, Lamia; Abroug, Fekri; Khelil, Jalila Ben; Besbes, Mohamed; Garnero, Aude; Arnal, Jean-Michel; Daviaud, Fabrice; Chiche, Jean-Daniel; Lortat-Jacob, Benoît; Diehl, Jean-Luc; Lerolle, Nicolas; Mercat, Alain; Razazi, Keyvan; Brun-Buisson, Christian; Durand-Zaleski, Isabelle; Texereau, Joëlle; Brochard, Laurent; Ben Khelil, Jalila; E.C.H.O.ICU Trial Investigators // American Journal of Respiratory & Critical Care Medicine;4/1/2017, Vol. 195 Issue 7, p871 

    Rationale: During noninvasive ventilation (NIV) for chronic obstructive pulmonary disease (COPD) exacerbations, helium/oxygen (heliox) reduces the work of breathing and hypercapnia more than air/O2, but its impact on clinical outcomes remains unknown.Objectives: To...

  • Low Tidal Volume Positive End-Expiratory Pressure versus High Tidal Volume Zero-Positive End-Expiratory Pressure and Postoperative Pulmonary Functions in Robot-Assisted Laparoscopic Radical Prostatectomy. Haliloglu, Murat; Bilgili, Beliz; Ozdemir, Mehtap; Umuroglu, Tumay; Bakan, Nurten // Medical Principles & Practice;Feb2018, Vol. 26 Issue 6, p573 

    Objective: The aim was to compare the effects of low tidal volume (VT) and moderate positive end-expiratory pressure (PEEP) with high VT and zero end-expiratory pressure (ZEEP) on postoperative pulmonary functions and oxygenation in patients undergoing robot-assisted laparoscopic...

  • Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort. Martinez, Carlos H.; Murray, Susan; Barr, R. Graham; Bleecker, Eugene; Bowler, Russell P.; Christenson, Stephanie A.; Comellas, Alejandro P.; Cooper, Christopher B.; Couper, David; Criner, Gerard J.; Curtis, Jeffrey L.; Dransfield, Mark T.; Hansel, Nadia N.; Hoffman, Eric A.; Kanner, Richard E.; Kleerup, Eric; Krishnan, Jerry A.; Lazarus, Stephen C.; Leidy, Nancy K.; O'Neal, Wanda // Annals of the American Thoracic Society;May2017, Vol. 14 Issue 5, p636 

    Rationale: Ever-smokers without airflow obstruction scores greater than or equal to 10 on the COPD Assessment Test (CAT) still have frequent acute respiratory disease events (exacerbation-like), impaired exercise capacity, and imaging abnormalities. Identification of these subjects...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics